TP53 and breast carcinoma: Apoptosis resistant cells often loose expression of tumor suppressors, such as p53 [3], [4], which is mutated in ∼50% of breast cancers, or gain expression of oncogenes such as AKT, which is overexpressed in ∼40% of breast cancers [5].